BioDelivery Sciences International, Inc. (OQ:BDSI)

Business Focus: Pharmaceuticals

Competitors with Recent Insider Filings
Merck & Co. (N:MRK)
Pfizer (N:PFE)
Odonate Therapeutics (OQ:ODT)
Latest 10 SEC filings (by transaction date) for BDSI within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 24th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 13/19 Jun 12/19 Sirgo Mark A Direct Ownership Common Stock S - Open market or private sale -177,495 $4.21
Jun 13/19 Jun 11/19 Sirgo Mark A Direct Ownership Options M - Exercise or conversion exempt under rule 16b-3 -25,000  
Jun 13/19 Jun 11/19 Sirgo Mark A Direct Ownership Options M - Exercise or conversion exempt under rule 16b-3 -22,369  
Jun 13/19 Jun 11/19 Sirgo Mark A Direct Ownership Options M - Exercise or conversion exempt under rule 16b-3 -37,348  
Jun 13/19 Jun 11/19 Sirgo Mark A Direct Ownership Common Stock S - Open market or private sale -307,257 $4.22
Jun 13/19 Jun 11/19 Sirgo Mark A Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 25,000 $3.47
Jun 13/19 Jun 11/19 Sirgo Mark A Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 22,369 $3.55
Jun 13/19 Jun 11/19 Sirgo Mark A Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 37,348 $3.90
Jun 5/19 Jun 3/19 Odonnell Francis E Jr Direct Ownership Common Stock S - Open market or private sale -8,000 $4.32
May 14/19 May 10/19 Broadfin Healthcare Master Fund Ltd Indirect Ownership Series B Convertible Preferred Stock C - Conversion 324 $10,000.00
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for BDSI within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 24th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 13/19 Jun 11/19 Sirgo Mark A Direct Ownership Options M - Exercise or conversion exempt under rule 16b-3 -25,000  
Jun 13/19 Jun 11/19 Sirgo Mark A Direct Ownership Options M - Exercise or conversion exempt under rule 16b-3 -22,369  
Jun 13/19 Jun 11/19 Sirgo Mark A Direct Ownership Options M - Exercise or conversion exempt under rule 16b-3 -37,348  
Jun 13/19 Jun 12/19 Sirgo Mark A Direct Ownership Common Stock S - Open market or private sale -177,495 $4.21
Jun 13/19 Jun 11/19 Sirgo Mark A Direct Ownership Common Stock S - Open market or private sale -307,257 $4.22
Jun 13/19 Jun 11/19 Sirgo Mark A Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 25,000 $3.47
Jun 13/19 Jun 11/19 Sirgo Mark A Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 22,369 $3.55
Jun 13/19 Jun 11/19 Sirgo Mark A Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 37,348 $3.90
Jun 5/19 Jun 3/19 Odonnell Francis E Jr Direct Ownership Common Stock S - Open market or private sale -8,000 $4.32
May 14/19 May 10/19 Broadfin Healthcare Master Fund Ltd Indirect Ownership Series B Convertible Preferred Stock C - Conversion 324 $10,000.00
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $BDSI

StockTwits